Diagnostic and Prognostic Value of Soluble Syndecan-1 in Pleural Malignancies
Figure 2
Soluble syndecan-1 levels in various malignant tumours. Significantly elevated soluble syndecan-1 levels were measured in several malignant tumours compared to benign disease. values are derived from Kruskal-Wallis tests, with Dunn’s post hoc tests. Benign asbestos pleuritis (BAP) and cancer of unknown primary (CUP). Where no values are stated, it indicates a nonsignificant association. Lines represent mean and error bars represent standard error of the mean (SEM).
